Chin-Yu Lin

ATLAS: Randomized, Double-Blind, Placebo-Controlled, Phase IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With Bevacizumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Bruce E. Johnson, Fairooz F. Kabbinavar, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2013 · 209 citations · Full text

Medicine, Oncology, Pharmacology +13

Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Jürgen Behr, Elisabeth Bendstrup, Bruno Crestani et al. · The Lancet Respiratory Medicine · 2016 · 164 citations

Medicine, Internal Medicine, Pharmacotherapy +11

An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)

Ulrich Costabel, Carlo Albera, Lisa Lancaster et al. · Respiration · 2017 · 151 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Intraperitoneal Radioimmunochemotherapy of Ovarian Cancer: A Phase I Study

Ruby F. Meredith, Ronald D. Alvarez, Edward E. Partridge et al. · Cancer Biotherapy and Radiopharmaceuticals · 2001 · 90 citations

Medicine, Oncology, Pharmacology +16

End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Arshad M. Khanani, David Callanan, Richard F. Dreyer et al. · Ophthalmology Retina · 2020 · 74 citations · Full text

Pharmacy, Ophthalmology, Pharmacotherapy +17